H22-Luc-hGPC3
Strain Information
Validation Data
1. In vitro Expression of H22-Luc-hGPC3 cell line
hGPC3 expression was measured in H22-Luc-hGPC3 cell by FACS . FACS results showed that significant hGPC3 expression on the H22-Luc-hGPC3 cell line.
Figure 1 hGPC3 expression in H22-Luc-hGPC3 cell line
2. Characterization of in vivo growth kinetics
To verify tumor formation of H22-Luc-hGPC3 cell line, cells were subcutaneously inoculated into female balb/c mice.
Figure 2. Tumor growth curve of H22-Luc-hGPC3 allogeneic model (n=5)
Figure 3. Body weight curve of H22-Luc-hGPC3 allogeneic model (n=5)
3. Expression of hGPC3 in tumors
To verify the hGPC3 protein expression, the tumors were dissected and separated for single cell suspension when he tumor volume is 500-1000mm3. Robust hGPC3 protein expression can be detected in the humanized modified tumors.
Figure 4. The expression of hGPC3 in humanized modified tumors by FACS
Related Strain(s)
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
